Pharmacy and clinic partnerships to expand access to injectable contraception

Journal of the American Pharmacists Association

Volumn 47, Issue 4, 2007, Pages 527-531

  Monastersky Maderas, Nicole J ^a   Landau, Sharon Cohen ^a  

^a PUBLIC HEALTH INSTITUTE   (United States)

Author keywords

Collaboration; Contraceptives; Injections; Medication adherence; Medication therapy management

Indexed keywords

CONTRACEPTIVE AGENT; MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; DELAYED RELEASE FORMULATION; FEMALE; HUMAN; INJECTION; MIDDLE AGED; PHARMACIST; PHARMACY;

ADULT; COMMUNITY PHARMACY SERVICES; CONTRACEPTIVE AGENTS, FEMALE; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; INJECTIONS; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; PHARMACISTS;

EID: 84891690424     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2007.06112     Document Type: Article

References (13)

1. Guttmacher Institute. Facts in brief: contraceptive use. Accessed at www.guttmacher.org/pubs/fb-contr-use.html, April 13, 2006.
2. Piccinino LJ, Mosher WD. Trends in contraceptive use in the United States: 1982-1995. Fam Plann Perspect. 1998;30:4-10.
3. U.S. Census Bureau. Census 2000 summary file 1. Washington, D.C.: U.S. Department of Commerce, Economics and Statistics Bureau; 2000.
4. Office of Family Planning. Family PACT program evaluation report. Sacramento, Calif.: California Department of Health Services; 2000:34.
5. U.S. Food and Drug Administration. FDA talk paper: black box warning added concerning long-term use of Depo-Provera contraceptive injection. November 17, 2004. Accessed at www.fda.gov/bbs/topics/ANSWERS/2004/ANS01325.html, April 13, 2006.
6. Kaunitz AM. Current options for injectable contraception in the United States. Semin Reprod Med. 2001;19:331-7.
7. Centers for Disease Control. Achievements in public health, 1990-1999: family planning. MMWR Morb Mortal Wkly Rep. 1999;48:1073-80.
8. World Health Organization. WHO statement on hormonal contraception and bone health. Accessed at www.who.int/reproductivehealth/family-planning/bone- health.html, January 11, 2006.
9. Lakha F, Henderson C, Glasier A. The acceptability of self-administration of subcutaneous Depo-Provera. Contraception. 2005;72:14-8.
10. Sneed R, Westhoff C, Morroni C, Tiezzi L. A prospective study of immediate initiation of depot medroxyprogesterone acetate contraceptive injection. Contraception. 2005;71:99-103.
11. Landau SC, Tapias MP, Taylor-McGhee B. Birth control within reach: a national survey on women's attitudes and interest in pharmacy access to hormonal contraception. Contraception. 2006;74:463-70.
12. Pharmacy Access Partnership. National survey on attitudes and interest for pharmacy access to hormonal contraception among women at risk for unintended pregnancy: 2004. Accessed at www.pharmacyaccess.org/Publications.htm, April 13, 2006.
13. Picardo C. Pharmacist-administered depot medroxyprogesterone acetate. Contraception. 2006;73:559-61.